Abstract:While disease-associated variants identified by genome-wide association studies (GWAS) most likely regulate gene expression levels, linking variants to target genes is critical to determining the functional mechanisms of these variants. Genetic effects on gene expression have been extensively characterized by expression quantitative trait loci (eQTL) studies, yet data from non-European populations is limited. This restricts our understanding of disease to genes whose regulatory variants are common in European populations. While previous work has leveraged data from multiple populations to improve GWAS power and polygenic risk score (PRS) accuracy, multi-ancestry data has not yet been used to better estimate cis-genetic effects on gene expression. Here, we present a new method, Multi-Ancestry Gene Expression Prediction Regularized Optimization (MAGEPRO), which constructs robust genetic models of gene expression in understudied populations or cell types by fitting a regularized linear combination of eQTL summary data across diverse cohorts. In simulations, our tool generates more accurate models of gene expression than widely-used LASSO and the state-of-the-art multi-ancestry PRS method, PRS-CSx, adapted to gene expression prediction. We attribute this improvement to the ability of MAGEPRO to more accurately estimate causal eQTL effect sizes (p<3.98x10^(-4), two-sided paired t-test). With real data, we applied MAGEPRO to 8 eQTL cohorts representing 3 ancestries (average n=355) and consistently outperformed each of 6 competing methods in gene expression prediction tasks. Integration with GWAS summary statistics across 66 complex traits (representing 22 phenotypes and 3 ancestries) resulted in 2,331 new gene-trait associations, many of which replicate across multiple ancestries, including PHTF1 linked to white blood cell count, a gene which is overexpressed in leukemia patients. MAGEPRO also identified biologically plausible novel findings, such as PIGB, an essential component of GPI biosynthesis, associated with heart failure, which has been previously evidenced by clinical outcome data. Overall, MAGEPRO is a powerful tool to enhance inference of gene regulatory effects in underpowered datasets and has improved our understanding of population-specific and shared genetic effects on complex traits.

XMAP: Cross-population Fine-Mapping by Leveraging Genetic Diversity and Accounting for Confounding Bias

Funmap: integrating high-dimensional functional annotations to improve fine-mapping

Genome-wide fine-mapping improves identification of causal variants

Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases

Finemap-MiXeR: A variational Bayesian approach for genetic finemapping

Evaluation of transethnic fine mapping with population-specific and cosmopolitan imputation reference panels in diverse Asian populations

Cell-type-specific mapping of enhancers and target genes from single-cell multimodal data

Efficiency of trans-ethnic genome-wide meta-analysis and fine-mapping

Leveraging the Local Genetic Structure for Trans-Ancestry Association Mapping

Probabilistic Fine-mapping of Putative Causal Genes

Leveraging Multi-ethnic Evidence for Mapping Complex Traits in Minority Populations: an Empirical Bayes Approach

Cross-Population Joint Analysis of eQTLs: Fine Mapping and Functional Annotation

Hierarchical joint analysis of marginal summary statistics—Part I: Multipopulation fine mapping and credible set construction

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics

Combining functional annotation and multi-trait fine-mapping methods improves fine-mapping resolution at glycaemic trait loci

Conditional Transcriptome-Wide Association Study for Fine-Mapping Candidate Causal Genes

Fine-mapping causal tissues and genes at disease-associated loci

Powerful mapping of cis-genetic effects on gene expression across diverse populations reveals novel disease-critical genes

JS-MA: A Jensen-Shannon Divergence Based Method for Mapping Genome-wide Associations on Multiple Diseases

CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses